ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,972.95
1.80%
US Tech 100
20,842.80
1.34%
Dow Jones
43,106.05
1.80%
Brent Oil
72.535
0.21%
Bitcoin
97,502.64
0.04%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Opko Health Inc (OPK) Quote

Opko Health Inc

Opko Health Inc (OPK)

NASDAQ
1.54
-0.03
( -1.91% )
Updated: 11:28:58
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.54
Bid
1.54
Ask
1.55
Volume
532,512
1.53 Day's Range 1.56
0.8516 52 Week Range 1.7585
Market Cap
1.051B
Previous Close
1.57
Open
1.545
Last Trade
41
@
1.545
Last Trade Time
11:29:25
Financial Volume
$ 820,298
VWAP
1.5404
Average Volume (3m)
3,899,026
Shares Outstanding
682,483,029
Dividend Yield
-
PE Ratio
-5.53
Earnings Per Share (EPS)
-0.28
Revenue
864.53M
Net Profit
-188.86M

About Opko Health Inc

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operatio... OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.opko.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Opko Health Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker OPK. The last closing price for Opko Health was $1.57. Over the last year, Opko Health shares have traded in a share price range of $ 0.8516 to $ 1.7585.

Opko Health currently has 682,483,029 shares outstanding. The market capitalization of Opko Health is $1.07 billion. Opko Health has a price to earnings ratio (PE ratio) of -5.53.

Ask ADVFN Intelligence (AI)

OPK Latest News

More News

NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer

NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer PR Newswire COCONUT GROVE, Fla., Dec. 10, 2024 Listing of OPKO Health-Branded...

December 10 2024
PR Newswire (US)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

November 20 2024
Edgar (US Regulatory)

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 36th Annual Healthcare Conference, being held...

November 20 2024
GlobeNewswire Inc.

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo PR Newswire COCONUT GROVE, Fla., Nov. 18, 2024 OPKO Healthcare's Veterinary Care...

November 18 2024
PR Newswire (US)

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results PR Newswire COCONUT GROVE, Fla., Nov. 14, 2024...

November 14 2024
PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

November 13 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

November 08 2024
Edgar (US Regulatory)

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates

JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today...

November 08 2024
GlobeNewswire Inc.

Form 8-K - Current report

November 07 2024
Edgar (US Regulatory)

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

MIAMI, Nov. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2024. Highlights from...

November 07 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0599-3.7439839991.59991.651.5347668771.59062585CS
4-0.02-1.282051282051.561.75851.4847448201.57585315CS
120.074.76190476191.471.75851.3738990261.5482837CS
260.2923.21.251.75851.1935799911.50738451CS
52-0.06-3.751.61.75850.851666006431.17439198CS
156-2.84-64.84018264844.385.250.851644440551.75473624CS
2600.042.666666666671.56.470.851663035002.75301653CS

OPK - Frequently Asked Questions (FAQ)

What is the current Opko Health share price?
The current share price of Opko Health is $ 1.54
How many Opko Health shares are in issue?
Opko Health has 682,483,029 shares in issue
What is the market cap of Opko Health?
The market capitalisation of Opko Health is USD 1.07B
What is the 1 year trading range for Opko Health share price?
Opko Health has traded in the range of $ 0.8516 to $ 1.7585 during the past year
What is the PE ratio of Opko Health?
The price to earnings ratio of Opko Health is -5.53
What is the cash to sales ratio of Opko Health?
The cash to sales ratio of Opko Health is 1.21
What is the reporting currency for Opko Health?
Opko Health reports financial results in USD
What is the latest annual turnover for Opko Health?
The latest annual turnover of Opko Health is USD 864.53M
What is the latest annual profit for Opko Health?
The latest annual profit of Opko Health is USD -188.86M
What is the registered address of Opko Health?
The registered address for Opko Health is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Opko Health website address?
The website address for Opko Health is www.opko.com
Which industry sector does Opko Health operate in?
Opko Health operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 5.18
(283.70%)
96.6M
APTOAptose Biosciences Inc
$ 0.3001
(76.32%)
197.81M
HSDTHelius Medical Technologies Inc
$ 0.835
(73.96%)
95.87M
OPTXSyntec Optics Holdings Inc
$ 3.17
(63.40%)
20.78M
PBMPsyence Biomedical Ltd
$ 3.98
(61.79%)
20.44M
CYNCYNGN Inc
$ 0.3954
(-75.44%)
16.84M
MTEMMolecular Templates Inc
$ 0.1379
(-60.60%)
4.87M
PRFXPainReform Ltd
$ 4.976
(-55.41%)
1.87M
GALTGalectin Therapeutics Inc
$ 0.90
(-55.00%)
6.54M
FNGRFingerMotion Inc
$ 1.3009
(-34.96%)
1.7M
APTOAptose Biosciences Inc
$ 0.3001
(76.32%)
197.81M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.6601
(15.81%)
169.8M
TAOPTaoping Inc BVI
$ 0.4294
(35.46%)
125.7M
RGTIRigetti Computing Inc
$ 9.3488
(25.15%)
117.79M
MYSZMy Size Inc
$ 5.18
(283.70%)
96.6M

OPK Discussion

View Posts
homeboy homeboy 1 week ago
Shorts are not covering because they are hedging with options..that’s my thoughts.
👍️0
PonkenPlonken PonkenPlonken 3 weeks ago
Clear tug of war here
Why does crooked Mr Frost continue to buy shares? And why do shorts not leave? About 30% of the float has been sold short, practically for ages.
👍️0
homeboy homeboy 1 month ago
EARNINGS: will probably show a profit with the part lab sale if they can Mickey Mouse the accounting. Cash reserve will be strong, but the real key is the forecast with the lab. Frost with his pig headed stubbornness has held on to this money sucking failure to OPKO’s demise. From nearly 20 at the time of purchasing the lab to a penny stock now.
Poor management …company runs on Frost’s money and not on making money.
👍️0
tredenwater2 tredenwater2 3 months ago
He can sell and leave yet, Dr. Frost needs to batten down the hatches on Star Island at his 60-80(?) million dollar mansion first from the ensuing Hurricane.

Almost like its Gods cleansing mechanism.
👍️0
MIKE18181 MIKE18181 3 months ago
Sell the company Phil and Leave the planet !
👍️0
tredenwater2 tredenwater2 4 months ago
Nice throwback. So, the gentleman that wrote the article back in 2019 (who was short on more than a few of Frost/honig stocks) was possibly a future “friend” of Frosts as he was quoted assaying in his past endeavors how many of those that bet against me (ie shorts) ended up becoming friends with him in the end.
👍️0
homeboy homeboy 4 months ago
https://hindenburgresearch.com/opko-health-if-these-sec-charges-were-surprising-then-you-havent-been-paying-attention/

Old article..some relevance today
👍️0
MIKE18181 MIKE18181 4 months ago
Yes, his age woukd be a reason also.
If its gonna do anything it soon.
👍️0
homeboy homeboy 4 months ago
Seems like the same story..we think they are setting up to sell the company. After the part sale closes, the remaining part of the lab could be sold to some other entity and Opko would become a research and development company (Modex). As a stand alone like this, it would be attractive to other pharma companies. We’ll be trading this from here on out. Synergies have momentum to the upside time being.
👍️0
MIKE18181 MIKE18181 4 months ago
Accounting made the -10m loss look smaller.
Curveball acconting since you like baseball. Closing of BRL not yet, so streamling was Not the real reason. Why, easy one you would have seen a loss in revenue as assets were sold.
So - 25,000,000 per quater minus axtual revene.
^Remember 100m in revs gone, as the unloaded BRL business segment.. 10% buy back is needed as the Dead Dog is obese with too many shares..
👍️0
game7alcs game7alcs 4 months ago
I decided to listen to todays call. It’s like listening to a call 10 years ago with different promising pipelines or should I say pipe dreams. Put your money to work elsewhere. You will be able to come back years from now and buy at these prices with your profits from actual investments.
👍️0
MIKE18181 MIKE18181 5 months ago
Bottom Line is the Bottom Line !
No earnings= No Action.
👍️0
homeboy homeboy 5 months ago
We expect some short covering with today’s news. Not earth shattering news, but positive in the short term.
👍️0
homeboy homeboy 5 months ago
WGS on the move higher and higher. This gives OPKO some much needed cash. It will be interesting to see how the part lab sale will affect the rest of the lab share OPKO retains…will they finally start making a consistent profit?
👍️0
homeboy homeboy 6 months ago
Hey Mike. I think the 80 million is the value of their holdings in WGS. Not bad,
👍️0
MIKE18181 MIKE18181 6 months ago
Frost made Money by having others perform the Finance. Hes Incompetant look at the resulrs. Frost got a free ride of otjers expertise.He is a Liar, farce, bullshetter.m He nows zip about financial mgmt. Hes a Fraud, and harmed shareholders. Going concern rating on broke Opk is a FACT !! A Fact !!!
👍️0
MIKE18181 MIKE18181 6 months ago
IMO, the 80million shares of Genedx is going to be unloaded. Word on the street is Opko is insolvent.. 155m in adj revenue and - 81million loss this is a horror show.
👍️0
game7alcs game7alcs 6 months ago
Hey Tred, good to hear from you. Yea it’s kind of a moot point that regardless of what is going on here, the shareholders are the ones getting the shaft. As usual.
👍️0
homeboy homeboy 6 months ago
OPK (Opko) short interest is very high.
👍️0
homeboy homeboy 6 months ago
Current Issues with OPK:
1). The part lab sale will lead to more cash on hand, but will it lead to better management and profitability of the remaining lab structure? 2) OPK last quarter issued 250 million shares to the treasury. OPKO is running out of cash on hand and will use these shares to fuel the company if needed. 3). WE expect that if the sale of the part lab is not done before the next conference call the stock will sell off and investors will take a wait and see approach.
👍️0
tredenwater2 tredenwater2 6 months ago
Game and Mike there is a possible chance that HF’s and other BP are suppressing the shareprice as a takeover maneuver to get at Opko’s IP. Dr. Frost Im sure has made or attracted many “future friends” along the way. History and God will be his judge and yes, I feel sorry for those that over invested and got taken to the cleaners and agree that not holding ones breath waiting for the halls of justice to save us is a good idea. We are but sucker fish on the smallest of bait in the sea when it comes to their priorities if ever.

Cheers

Tred
👍️0
game7alcs game7alcs 6 months ago
If you think Dr Frost is corrupt you should take a look at our DOJ, SEC and other govt agencies. They make Dr Frost look like Mother Theresa. They aren’t going to help the shareholders here recover from a bad investment in a highly speculative company.
👍️0
MIKE18181 MIKE18181 6 months ago
Department of justice (DOJ, SEC and more). We dont want an anti trust or monopoly or unfair business / competion that hurts consumers !!!

Ok, listen.. but you allow a CEO Phillip Frost to control the common stock, Mislead, Lie , Harm hardworkibg shareholders..
Look at the results since 2006.
Should have been fired for losses to all Opk shareholders. " to be held accoutable for lack of performance "...
👍️0
MIKE18181 MIKE18181 6 months ago
Takeout price is 3.00 IMO
👍️0
homeboy homeboy 7 months ago
Looks like a positive turn of events while we were away. They are setting this up for an eventual sale..perhaps not this year, but I think it’s coming. Probably an all stock offer from some other Pharma company. I don’t see anyone offering them cash for a company that hasn’t and isn’t making money. This endeavor for the Dr. has been a colossal failure for most investors. A lot of hype over the years and not delivering on the goods. Take care everyone. We’ll hold our position until we see a good exit point.
👍️0
tredenwater2 tredenwater2 8 months ago
Makes one wonder after looking at the trading pattern of CDXC (whom Dr. Frost is connected with) if OPK will do the same in the near future. Transfer of wealth in a very coordinated manner imo.
👍️0
tredenwater2 tredenwater2 9 months ago
What a shet show! Millions and millions of shares trade on Monday and 10 million plus today and the stock barely climbs. Let me guess, it was a quadruple whitching Monday and the moon was full? I have to admit I have never seen trading like this, is this even legal?

This stock is flat out evil. Whoever is manipulating it is surely going to hell in a hand basket. Outright greed imo strip mining shareholders of absolutely any chances here. Not even fun to watch the crazy shenanigans going on.

Ive lost the last 2.5% respect I had for Dr. Frost and team of which 1.5% of it was for Dr. Jane Hasao. They could solve world hunger and I wouldnt even bat an eye. This is text book bullshet!
👍️0
tredenwater2 tredenwater2 9 months ago
If that is true it is very sad to hear Mike. I lost money a couple of times but was able to profit very early in 2015/16 before the HFT AI trading took over. You are but one of many that have been systematically “cycled” out of their money. The trading of this stock appears to be so robotic, almost programmed through AI squeezing every last penny out of investors. Maybe one day Dr. Frost will have to answer here on earth for why he was so incompetent at the helm of a company he holds and continues to buy many millions of shares of stock of.

Do not worry, God will “settle” his trades.

Happy Easter!

Tred
👍️0
MIKE18181 MIKE18181 9 months ago
I sold every Opko share and Lost 437,000 dollars and my retirement money is all gone.
I sold all of it at 90 cents down to 86 cents.
Wiped out.. and then it went up to 1.25
Even at 1.25 I still lost 95 % .
Frost got away with it! SEC would not award me 1.00 buck
👍️0
MIKE18181 MIKE18181 9 months ago
88 cents and dropping. Chart momentum was showing it even with Frost buying.
Not looking good.
👍️0
MIKE18181 MIKE18181 9 months ago
Yes, I wrote about Yvonne Briggs IR, and said as I asked a simple question, I started to probe other harder.
Result backed off, and told me to read the Q reports . I called you, because you the Investir relation support. I got more calls gotta go.
This will be sold and the time frame to me looks like 2 qtrs
👍️0
homeboy homeboy 9 months ago
The reason we ask questions directly to management is there is an underlying tone that is not open with this company. I highlighted that with Adam Logal during the conference call mentioning the repurchase of shares. That was a deflection from what was really going on… Yvonne tries to come across as being open at the investor relations department. As a former business owner, I can assure you what you get from investor relations is scripted to what has been publicly released only. Behind the scenes is a different world. We (our team of investors) are betting on some type of buyout. Elias is in his 70s, Frost is near 90. Those are the main characters. Both cut from the same mold…grow the business, then sell it. Very common practice.
What Yvonne tells about the current outstanding shares is only part of the story. In a buyout, many of those reserved shares would also have to be honored. So, being conservative 1,000,000,000 shares at this point would be the buyout amount. For example: a buyout at 7 dollars would represent a 7 billion dollar purchase. Modex has value potential we think. As many here have said, the lab has been a nemesis and OPKO has not reacted fast enough. There was a reason the former owner was happy to sell Bio for 1.5 billion. We can see clearly now. But what remains a mystery is why OPKO continues to fund it at a deficit in the hundreds of millions? On another note…
We will be traveling for a while until mid June to China. Until then, hopefully OPKO will have some good fortune during the interim.
👍️0
MIKE18181 MIKE18181 9 months ago
Good information Homeboy, I talk about that a while back. I knew that the casflow statements and Income statement never were fixed.... Issuance was the only quick savior.
This 1,000,000 share buying is not going to solve the perception from the destroyed Audience.
A sold company would...
👍️0
homeboy homeboy 9 months ago
I inquired about the specifics to increase the share count:

“The Board has unanimously adopted and declared advisable, and has recommended that the Company's stockholders approve, the Charter Amendment, which would amend the Certificate of Incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 1,250,000,000.

In addition to the 726,764,700 shares of common stock issued and outstanding (including treasury shares) as of the record date, the Board has reserved an aggregate of 418,733,078 additional shares for future issuance, consisting of the following: (a) 53,731,069 shares reserved for issuance upon the exercise of outstanding employee stock options; (b) 32,912,579 shares reserved for future issuance of awards under the 2016 Equity Incentive Plan; (c) 48,295 shares reserved for issuance upon conversion of the Company's outstanding 4.50% convertible senior notes due 2025 issued in February 2019; (d) 8,489 shares reserved for issuance upon conversion of the Company's outstanding 2033 convertible senior notes issued in January 2013; and (e) 332,032,646 shares reserved for issuance upon conversion of the Company's outstanding 3.75% Convertible Senior Notes due 2029 issued in January 2024.

As a result, the Company currently has no authorized but unissued shares of common stock (including treasury shares) that are unreserved and available for future issuance.”
👍️0
MIKE18181 MIKE18181 9 months ago
This stock Opko is getting spanked , I hope something is coming. . 775m @ 2bucks 3 4 5 6 7 8 × the outstanding or unload BRL.
Genedx holdings went way up after 1.16 slide.
So, they don't need just cash they need a SANE financial plan..
👍️0
game7alcs game7alcs 9 months ago
Dr Frost has absolutely nothing zero nadda up his sleeve. I check back once in a while and still the same nonsense. Sell. Get out with what little you have left.
👍️0
homeboy homeboy 9 months ago
Frost must have something up his sleeve. He alluded to that without letting the cat out of the bag during the conference call. We are holding our position. A little under water.
👍️0
MIKE18181 MIKE18181 9 months ago
Yes, I also paid attention to what Elias said.
And the chang up to this year. I heard last year by the 1st quarter of 24. . These continued misses is why recommending from a brokerage to clients, Institutional and the public they sold and lowered holdings . Did here it right.
1.4 m on pfe 3rd qtr / and 12m on q4 pfe
Covering the expenditures from this, needs a budget . Weight loss drug, good luck !
👍️0
homeboy homeboy 9 months ago
Elias, whom I like, a year ago talked about being at break even with the lab by 2024. That didn’t happen and in the last conference call he regurgitated his remarks from a year ago that to be profitable sometime this year. Price reflects the lack of execution. The lab is the cause for the price as you say Mike..it has been choking OPKO since the purchase. Frost mentioned the lab was making 100 million a year at the time of purchase…I am starting to have my doubts about that statement.
With the new note deal, Frost will have/has more than 300 million shares. Logal wanted to highlight during the recent conference call that OPKO bought back 50 million shares with the note deal. That is just part of the deal. He failed to mention OPKO also had to reserve approximately 200 million just in case the notes are not repurchased. Dilution possibly to the tune of 150 million shares give or take.
Like you mentioned Mike, something has to give. One of the stocks we owned was KOPN and during the pandemic it went below 40 cents and on a squeeze went to 12 bucks before retreating. Frost stated the repurchase of the 50 million shares would put a floor in on the stock price right about where it is. There is 94 cents below the floor??
👍️0
MIKE18181 MIKE18181 10 months ago
.93 cents Dude.. Does the cash on hand and upcoming losses gonna give this a down draft.
Some analyst believe .-30 for 2024 FY
Dicey or play the rocking chair trades
Back and forth. Back to 1.00 or 1.01
Regardless, IMO this can't last much longer
👍️0
homeboy homeboy 10 months ago
“Market makers can influence stock prices by buying or selling stocks in large trading volume.”
👍️0
MIKE18181 MIKE18181 10 months ago
Exactly, I said 3 quarters of cash. Yes concern for the burn. If you being choked, pull the hand from your throat. The point is they will collapse without action. This is Bad man.
Cheap got cheaper, and more cheaper.
Wedsday trading will be down
👍️0
MIKE18181 MIKE18181 10 months ago
Exactly, I said 3 quarters of cash. Yes concern for the burn. If you being choked, pull the hand from your throat. The point is they will collapse without action. This is Bad man.
Cheap got cheaper, and more cheaper.
Wedsday trading will be down
👍️0
homeboy homeboy 10 months ago
Conference call revealed, reading between the lines, there is about 2 quarters of cash on hand to carry the losses. One analyst asked about disengaging from Bio and becoming a pharma only business. Take care everyone.
👍️0
MIKE18181 MIKE18181 10 months ago
Price to book ratio is .57, 1.00 is acceptable.
Investors say look Opko is Undervalued.
The real detection is " Financial distress "..
Be careful, and yes it could punch the wallet even more Cheap means something, and nobody is beating a path to buy at under a Buck..
It's mismanaged and Risky..
👍️0
homeboy homeboy 10 months ago
Revenue matches market cap pretty much. Thinking it can’t go lower can be dangerous to the wallet. Market makers will release the leash when they see fit. OPKO management is not moving fast enough to cure the constant loss per quarter. The note deal was self serving…and we will never know the full details. Warrants for the 230 mil at 5 bucks a share would have been a healthy way to instill trust. I don’t blame Frost for doing what he did. This company would have dried up long ago without his money. Have a good week…earnings Tuesday after market. Although they are guided to lose money the best we can expect is that they beat the loss and good news of some sort for the near future. Take care.
👍️0
MIKE18181 MIKE18181 10 months ago
Opko stock will be on sale this week.
👍️0
homeboy homeboy 10 months ago
Not sure what they think they can accomplish with NextPlat in a country where the government owns all the land (people can buy a home, but not the land), and people are poor. I’m not expecting anything money wise to come from this. We are in a bear trap…the only way out is good corporate news. Take care everyone.
👍️0
game7alcs game7alcs 10 months ago
Yea you can’t. Teaming up with this company is the act of a penny stock company. That’s all I think. Hope you bought cheap shares and don’t lose much like most people have.
👍️0
MIKE18181 MIKE18181 10 months ago
Opko selling dog food? Is it true ?? and do they want to just set up a Limited Partnership to " short there own stock somemore" .
I hope there is a mention of financial Eps impact
When can you believe these guys about any development.??
👍️0

Your Recent History

NASDAQ
OPK
Opko Health
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads